Self-Stigma and Treatment Effectiveness in Patients with SSRI Non-Responsive Obsessive-Compulsive Disorder.
cognitive behavioral therapy
exposure and response prevention
non-response
obsessive compulsive disorder
self-stigma
Journal
Psychology research and behavior management
ISSN: 1179-1578
Titre abrégé: Psychol Res Behav Manag
Pays: New Zealand
ID NLM: 101514563
Informations de publication
Date de publication:
2021
2021
Historique:
received:
18
10
2020
accepted:
04
01
2021
entrez:
12
2
2021
pubmed:
13
2
2021
medline:
13
2
2021
Statut:
epublish
Résumé
Obsessive compulsive disorder (OCD) is a debilitating mental disorder that often takes a chronic course. One of the factors influencing the treatment effectiveness in anxiety and depressive disorders is the self-stigma. This study focused on the relationship between the self-stigma, symptomatology, and therapeutic outcomes in patients with OCD. Ninety-four inpatients with OCD, who did not sufficiently respond to at least one selective serotonin reuptake inhibitor trial, participated in the study. They attended a six-week therapeutic program consisting of exposure and response prevention, transdiagnostic group cognitive behavioral therapy, individual sessions, mental imagery, relaxation, sport, and ergotherapy. The participants completed several scales: the Internalized Stigma of Mental Illness Scale (ISMI), the self-report Yale-Brown Obsessive Compulsive Scale (Y-BOCS-SR), Beck Anxiety Scale (BAI), Beck Depression Scale-II (BDI-II), and Dissociative Experiences Scale (DES). A senior psychiatrist filled in the Clinical Global Impression (CGI-S). The average scales' scores considerably declined in all measurements except for DES. The self-stigma positively correlated with all psychopathology scales. It was also higher in patients with a comorbid personality disorder (PD). The higher self-stigma predicted a lower change in compulsion, anxiety, and depressive symptoms but not the change of obsessions or the overall psychopathology. The self-stigma presents an important factor connected to higher severity of OCD. It is also a minor predictor of a lower change in symptomatology after combined treatment.
Identifiants
pubmed: 33574718
doi: 10.2147/PRBM.S287419
pii: 287419
pmc: PMC7873032
doi:
Types de publication
Journal Article
Langues
eng
Pagination
85-97Informations de copyright
© 2021 Ociskova et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest in this work.
Références
J Thorac Dis. 2016 Sep;8(9):E928-E931
pubmed: 27747028
Neuro Endocrinol Lett. 2017 May;38(2):98-106
pubmed: 28650603
Neuro Endocrinol Lett. 2009;30(5):615-23
pubmed: 20035255
Gen Psychiatr. 2020 Mar 11;33(2):e100180
pubmed: 32215363
J Anxiety Disord. 2015 Jun;33:15-24
pubmed: 25956558
Actas Esp Psiquiatr. 2007 Jul-Aug;35(4):229-35
pubmed: 17592784
Neuropsychiatr Dis Treat. 2016 Sep 22;12:2439-2448
pubmed: 27703362
Neuropsychiatr Dis Treat. 2015 Jul 17;11:1767-79
pubmed: 26229471
Clin Psychol Psychother. 2020 Mar;27(2):239-248
pubmed: 31910308
J Clin Psychiatry. 2006 Feb;67(2):269-76
pubmed: 16566623
Neuro Endocrinol Lett. 2014;35(7):624-32
pubmed: 25617887
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S467-72
pubmed: 22588767
Depress Anxiety. 2011 Jun;28(6):495-500
pubmed: 21509914
Compr Psychiatry. 2017 Jul;76:79-86
pubmed: 28433854
Brain Struct Funct. 2014 Jul;219(4):1321-31
pubmed: 23681167
Arch Psychiatr Nurs. 2004 Jun;18(3):88-96
pubmed: 15199536
Int J Neuropsychopharmacol. 2002 Jun;5(2):181-91
pubmed: 12135542
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
pubmed: 2684084
Epidemiol Psychiatr Sci. 2018 Apr;27(2):176-185
pubmed: 27974084
Braz J Psychiatry. 2004 Sep;26(3):141-2
pubmed: 15645057
Clin Psychol Rev. 2015 Aug;40:156-69
pubmed: 26117062
Neuropsychiatr Dis Treat. 2016 Jun 24;12:1539-51
pubmed: 27445474
J Cent Nerv Syst Dis. 2016 Aug 21;8:13-29
pubmed: 27594793
Psychol Med. 2003 May;33(4):611-22
pubmed: 12785463
J Pers Assess. 1996 Dec;67(3):588-97
pubmed: 8991972
Am J Psychiatry. 1993 Nov;150(11):1737-8
pubmed: 8214187
J Anxiety Disord. 1998 Sep-Oct;12(5):463-83
pubmed: 9801964
BMJ Open. 2017 Aug 29;7(8):e018228
pubmed: 28851803
J Consult Clin Psychol. 1988 Dec;56(6):893-7
pubmed: 3204199
Soc Sci Med. 2010 Dec;71(12):2150-61
pubmed: 21051128
Neuropsychiatr Dis Treat. 2016 Oct 17;12:2659-2676
pubmed: 27799774
Depress Anxiety. 2013 Aug;30(8):763-72
pubmed: 23109056
Neuropsychiatr Dis Treat. 2018 Jan 26;14:383-392
pubmed: 29416340
J Affect Disord. 2015 Jan 15;171:74-84
pubmed: 25299438
Soc Psychiatry Psychiatr Epidemiol. 2014 Aug;49(8):1287-96
pubmed: 24213522
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Clin Psychopharmacol Neurosci. 2018 May 31;16(2):161-167
pubmed: 29739129
Depress Anxiety. 2009;26(1):39-45
pubmed: 18800368
Clin Psychol Rev. 2013 Dec;33(8):1067-81
pubmed: 24077387
Int J Neuropsychopharmacol. 2005 Mar;8(1):107-29
pubmed: 15450126
Acta Psychiatr Scand. 2009 Feb;119(2):98-106
pubmed: 18822090
Ind Psychiatry J. 2009 Jan;18(1):39-42
pubmed: 21234161
Am J Psychiatry. 2007 Mar;164(3):500-8
pubmed: 17329476
Compr Psychiatry. 2015 Nov;63:30-5
pubmed: 26555489
J Community Psychol. 2019 Apr;47(3):698-705
pubmed: 30499106
World J Clin Cases. 2014 Aug 16;2(8):327-31
pubmed: 25133142
Neuropsychiatr Dis Treat. 2016 Oct 07;12:2539-2552
pubmed: 27785031
Psychiatry Res. 2003 Nov 1;121(1):31-49
pubmed: 14572622
Neuro Endocrinol Lett. 2015 Dec;36(7):706-12
pubmed: 26859595
J Clin Psychiatry. 2013 Mar;74(3):233-9
pubmed: 23561228
Clin Psychol Rev. 2014 Apr;34(3):256-71
pubmed: 24682109